- EUROAPI has partnered with Swedish contract research organisation (CRO) SpiroChem.
- The partnership aims to offer customers a consolidated CRO-CDMO solution.
- This collaboration enhances EUROAPI’s CDMO capabilities
EUROAPI has announced a strategic partnership with Spirochem, a Swedish contract research organisation. This collaboration is set to enhance EuroAPI’s contract development and manufacturing organisation (CDMO) capabilities, offering its customers a consolidated CRO-CDMO solution.
The partnership comes at a time when the demand for integrated CRO-CDMO services is on the rise. By joining forces with SpiroChem, EUROAPI is positioning itself to better meet this demand and provide comprehensive solutions to its customers.
“By adding a renowned CRO partner like SpiroChem to our existing R&D and industrial offering, this fruitful collaboration will strengthen our market position and accelerate our CDMO roadmap”, said Cécile Maupas, Chief CDMO Officer of EUROAPI.
“Having EUROAPI as a partner brings a substantial value to SpiroChem’s customers who are looking for reliable CDMOs to rapidly and seamlessly scale up the innovative solutions developed by SpiroChem”, said Thomas Fessard, CEO and co-founder of SpiroChem.
The partnership is expected to bring significant benefits to both EUROAPI and SpiroChem, as well as their customers. It represents a strategic move by EUROAPI to strengthen its position in the competitive CDMO market.